X-linked agammaglobulinemia diagnosed in adulthood: a case report

Int J Hematol. 2006 Aug;84(2):154-7. doi: 10.1532/IJH97.06095.

Abstract

X-linked agammaglobulinemia (XLA) is a humoral immunodeficiency caused by mutations in Bruton's tyrosine kinase (BTK). Patients typically become symptomatic during infancy or early childhood and develop recurrent bacterial infections. We report a Japanese case of XLA diagnosed in a patient who was 27 years of age and who had no history of severe infection. The patient's serum immunoglobulin (Ig) G, IgA, and IgM levels were 132,7, and 17 mg/dL, respectively. The percentage of positive cells for CD19 and CD20 was 0.03% and 0.02%, respectively. The patient's brother and sister had no abnormalities. Flow cytometric analysis showed a partially reduced expression of BTK protein in the patient's peripheral monocytes. Sequencing of the BTK. gene revealed a missense mutation (230C>T,T33I). Given this data, this patient was diagnosed as having rare, late onset XLA with a missense mutation in the BTK gene.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Agammaglobulinaemia Tyrosine Kinase
  • Agammaglobulinemia / blood
  • Agammaglobulinemia / genetics*
  • Agammaglobulinemia / microbiology
  • Asian People
  • Bacterial Infections / blood
  • Bacterial Infections / genetics
  • Gene Expression Regulation, Enzymologic / genetics
  • Genetic Diseases, X-Linked / blood
  • Genetic Diseases, X-Linked / genetics*
  • Genetic Diseases, X-Linked / microbiology
  • Humans
  • Immunoglobulins / blood
  • Japan
  • Leukocyte Count
  • Male
  • Mutation, Missense*
  • Protein-Tyrosine Kinases / biosynthesis
  • Protein-Tyrosine Kinases / genetics*

Substances

  • Immunoglobulins
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human